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Background to the Hertfordshire Cohort Study
In the 1980s, ecological studies showed that death rates from 
heart disease in the 212 local authority areas of England and 
Wales during 1968–78 were correlated with infant mortality rates 
in those areas in the early part of the 20th century1. This raised 
the possibility that environmental influences acting during the 
fetal and infant stages of development might increase risk of 
cardiovascular disease in later life.
However, stronger evidence from a more robust epidemiological 
study design was required. The discovery of a large set of 
birth records for people born in Hertfordshire during the first 
half of the twentieth century provided an opportunity for the 
MRC Environmental Epidemiology Unit (MRC EEU) to establish 
a cohort study in which the early origins of disease in later life 
could be explored.
The Hertfordshire birth records
In 1911, a team of midwives and nurses was assembled in 
Hertfordshire with the aim of improving the health of children 
in the county. Midwives attended women during childbirth and 
health visitors routinely visited the child throughout infancy 
and childhood; weight at birth and one year of age, method of 
infant feeding, illnesses, and developmental milestones were all 
recorded. The information (Table 1) was transcribed into ledg-
ers (Figure 1) at the County Health Department in Hertford. The 
ledgers cover almost all births in Hertfordshire from 1911 until 
the NHS was formed in 1948.
Studies based on men and women born in Hertfordshire 
1911–30
The MRC EEU computerised the Hertfordshire ledgers and 
traced the cohort by linkage with the National Health Service 
Central Register (NHSCR). A mortality study of 15,000 men 
and women born between 1911–30 showed that lower weight at 
birth and one year of age was associated with increased risk 
of death from cardiovascular disease by 75 years of age2. 
Subsequently, numerous detailed physiological studies were 
conducted among community dwelling men and women born 
in Hertfordshire between 1920–30 and still living there in the 
early 1990s. Small size in early life was associated with greater 
risk of cardiometabolic disease3–5, osteoporosis6 and sarcopenia 
(the loss of muscle mass, strength and function with age)7 in 
later life. Collectively these studies contributed to the “devel-
opmental origins” hypothesis which suggests that the nourish-
ment a baby receives in utero, and its development in infancy 
and early childhood, determine its risk of disease in later 
life8.
These early studies were important for establishing relation-
ships between the early environment and physiological markers 
of disease, but they lacked detailed information on adult 
anthropometry and diet, and the men and women born 1920–30 
were becoming frail and unable to take part in further studies. 
A second (younger) cohort, in whom the work could be 
continued, was therefore recruited between 1998–2004. During 
this time Professor Cyrus Cooper became Hertfordshire Cohort 
Study (HCS) principal investigator and the MRC EEU was 
reconfigured as the MRC Lifecourse Epidemiology Unit (LEU), a 
University Unit Partnership between the MRC and the University 
of Southampton.
Key methods
The younger cohort comprises 3000 men and women born 
between 1931 and 1939 who were traced following the model 
of the early studies. These are the people to whom the term ‘The 
Hertfordshire Cohort’ specifically applies. The remainder of this 
paper applies only to them, unless otherwise stated.
Table 1. Hertfordshire Health Visitors’ ledgers.
Key data availability:















From age 1–5 years  
   •   General comments on health
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Figure 1. An extract from the Hertfordshire ledgers. Source: original Hertfordshire  ledger, on loan from the Hertfordshire Local Studies 
Archive; currently stored securely at the MRC LEU.
Objective of the Hertfordshire Cohort Study
The principal objective of the HCS is to evaluate interactions 
between the intra-uterine and early postnatal environment, 
adult diet and lifestyle, and genetics, in the aetiology of chronic 
disorders of ageing (osteoporosis, osteoarthritis, sarcopenia, 
obesity, cardiometabolic disease and type II diabetes mellitus). 
The study aims to place these interactions within a life-course 
model for disease pathogenesis, and to characterise the physi-
ological mechanisms underlying the pathways to these chronic 
disorders.
Baseline recruitment 1998–2004
The baseline recruitment of HCS participants has been described 
in detail previously9; key stages in the process are shown in 
Figure 2. In brief, the ledgers contained records for 42974 births 
in Hertfordshire between 1931 and 1939; the National Health 
Service Central Register (NHSCR) in Southport (now part of 
NHS Digital) traced 8650 men and women who were still alive 
in Hertfordshire in 1998. Permission to contact 6099 men and 
women by letter was obtained from their GPs and 3225 (53%) 
agreed to a home interview with a trained research nurse. 2997 
(93%) men and women subsequently attended a clinic for detailed 
physiological investigations. The baseline HCS fieldwork was 
county-wide but conducted in phases by geographical area and 
gender. 966 (68%) of the 1412 men and women who attended 
clinic in East Hertfordshire also underwent a Dual-energy X-ray 
Absorptiometry (DXA) bone scan and knee radiography. An 
overview of the data collected at the HCS baseline home interviews 
and clinics is provided in Table 2.
Ethical permission and informed consent
The HCS baseline investigations had ethical approval from 
the Hertfordshire and Bedfordshire Local Research Ethics 
Committee and all subjects gave written informed consent. All 
interviews and physiological investigations were carried out 
according to strict protocols and studies of within- and between- 
observer variation were conducted at regular intervals during 
fieldwork to ensure comparability of measurements obtained 
over time. Data were collected, anonymised, processed and 
stored in accordance with contemporary data protection 
regulations. Participants are free to withdraw from the study at 
any time.
Follow-up studies 2004 to 2018
Since their first contact in 1998–2004, HCS cohort members 
have generously agreed to take part in various follow-up 
postal questionnaires, face-to-face interviews, clinics, interven-
tion studies, and focus groups (see Figure 2). With their consent, 
data on hospital admissions experienced by the cohort members 
across a decade have been obtained from NHS Digital10, and 
cohort members remain flagged on the National Health Service 
Central Register for ongoing notification of mortality. Ethical 
approval was obtained for all elements of the study at the time 
they were conducted.
Table 3 to Table 11 describe the scientific objective and meth-
odology of each HCS follow-up study and detail key data 
availability. Taken together, the HCS datasets provide a rich, 
detailed and longitudinal characterisation of the sociodemo-
graphic, lifestyle, medical and biological attributes of a contem-
porary group of community-dwelling older men and women 
in the UK.
Key findings
HCS is a particularly valuable resource for research that 
aims to identify lifecourse influences on ageing. Longitudinal 
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Figure 2. Participant recruitment and summary of studies carried out from 1998–2018.
measurements are available for a range of markers of disease 
and for potential predictor and confounding variables. The study 
has been pioneering in its uptake of techniques not previously 
used in epidemiology to characterise health (for example High 
Resolution peripheral Quantitative Computed Tomography 
(HR pQCT) scanning and muscle biopsy) and has sought to 
maximise the value of routinely collected data through record 
linkage.
The following sections outline key publications in the areas of 
osteoporosis, osteoarthritis, sarcopenia and diet.
Osteoporosis
Osteoporosis is the most common metabolic bone disease 
affecting older people; almost one in two women and one in five 
men aged 50 years will have an osteoporotic fracture in their 
remaining lifetime11. The LEU is a renowned contributor to 
research on osteoporosis, in part because of the wealth of data 
collected in HCS (Table 2–Table 12). Estimates of bone min-
eral density (BMD) and bone mineral content (BMC) have been 
obtained by DXA; estimates of bone strength (including 
strength strain index (SSI)), cortical bone and trabecular bone by 
peripheral Quantitative Computed Tomography (pQCT); and 
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Table 2. Hertfordshire Cohort Study Baseline.
Key data availability












































































‘virtual bone biopsies’ by HR pQCT. Few other cohorts have 
characterised bone in such detail.
Predictors of osteoporosis. The Health Visitors’ records that 
are uniquely available in HCS have enabled investigation of the 
early-life origins of osteoporosis. Studies using DXA showed 
an increase in adult BMC with rising weight at birth, and more 
strongly, with weight at one year. Models that also included 
weight in adulthood showed impacts accruing from each time-
point, with greater contributions of early growth to BMC than to 
BMD12. In addition, growth during the first year was shown to 
alter the geometry of the adult hip13. Studies using pQCT showed 
that bone strength was similarly related to early weights14.
Risk of osteoporosis attributable to lifestyle has also been 
investigated in this cohort. While no social patterning has 
been observed15, nor any relationship found between cigarette 
smoking, alcohol use, or physical activity and either BMC or 
BMD16, alcohol has been associated with less radial cortical 
and trabecular bone in men and less tibial trabecular bone in 
women17. Clustering of risk factors (physical activity, diet, 
alcohol consumption, smoking behaviour, grip strength, per-
sonal and family interactions, comorbidities) has been found to 
increase the risk of low BMD in women18. Also in women, pQCT 
scans have shown that having a ‘healthier’ diet (characterised by 
greater consumption of fruit, vegetables and wholegrain cereals) is 
associated with increased bone area on pQCT scanning19. 
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Some lifestyle risk factors appear to interact with early life 
factors to influence osteoporosis risk, for example, in men, having 
a low birth weight and being a current smoker increased the 
risk of low femoral BMD16.
Osteoporosis and comorbidity. HCS has provided valuable 
insight into the interplay between osteoporosis and other chronic 
conditions. For example, in the case of cardiometabolic disease, 
analyses have shown that: BMD is associated with serum triglyc-
erides and HDL22; higher BMI is associated with lower 25(OH) 
vitamin D23; arterial calcification affects the structure of cortical 
and trabecular bone in women, but not in men24; hyperinsuline-
mia influences BMD through BMI25; and the associations between 
lean and fat mass and bone microarchitecture differ26. In the 
case of chronic inflammation in later life (inflammaging), HCS 
has shown that an elevated inflammatory state is associated 
with reduced BMD at baseline and with an accelerated rate of 
decline over time27. Relationships between muscle and bone health 
are discussed in the section on sarcopenia that follows.
Outcomes of osteoporosis. The primary outcome of osteoporosis 
is fracture, which carries high personal and societal costs. Risk of 
fracture has been elucidated in HCS, showing, for example, that 
history of falls adds to clinical risk factors and low BMD as a 
risk factor for fracture28. Research using pQCT scans has shown 
that in women, cortical radial thickness and area, and tibial cor-
tical area and density, are associated with adult fracture risk, and 
in men tibial SSI is associated with adult fracture risk29. Finally, 
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cluster analysis of bone microarchitecture from HR pQCT has 
demonstrated two separate phenotypes associated with high 
fracture risk31.
Osteoarthritis (OA)
OA is the most common joint disease affecting older people32. It 
is an important element of the research programme of the LEU 
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and its incorporated Arthritis Research UK MRC Centre for 
Musculoskeletal Health and Work. In HCS, radiographic, clinical 
and self-reported markers of OA have been collected at multiple 
time points (Table 2–Table 12).
Descriptive epidemiology. HCS data have been used to show that 
the method of ascertainment of OA status affects both its calcu-
lated prevalence33 and the demographic characteristics with which 
it is associated34. For example, prevalence of knee OA ranged 
from 18% for clinically diagnosed disease through 21% for 
self-reported disease to 42% when the diagnostic criteria were 
radiographic; with higher specificity and lower sensitivity for 
clinical and self-reported OA than for radiographically deter-
mined disease33. Further work utilising data for multiple methods 
of ascertainment showed that in the presence of radiographically 
determined disease in the knee, signs and symptoms differed 
dependent on the bones involved, tibiofemoral OA being 
associated with both signs and symptoms, and patellofemoral 
OA only with clinical signs35.
Predictors of OA. Results from this study have demonstrated 
that growth before birth and in the first year both affect the 
likelihood of developing OA in later life36. Specifically, an 
increase in number of osteophytes on hip radiographs has been 
associated with low birthweight and the number on knee radio-
graphs with low weight at 1 year. An increased prevalence of 
clinical OA at the hand was also seen in those whose weight 
at 1 was low. Conversely, rheumatoid arthritis was not associated 
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with early weight37. The role of biochemical markers of bone in 
the aetiology of OA has also been investigated, finding that CTX-II 
and glucosyl-galactosyl-pyridinoline were associated with both 
osteophyte score and joint-space narrowing, whist CTX1 and 
osteocalcin were not38.
Outcomes of OA. The consequences of OA include an increase 
in the impact of objectively measured neighbourhood problems 
on participants’ physical activity39 and quality of life40. Pain 
is an important symptom of OA which, in HCS and other 
EPOSA cohorts, has been found to fully explain the association 
of OA with objectively measured (but not with self-reported) 
physical function41. This suggests that individuals consider fac-
tors other than pain (e.g. comorbidity) in making an assessment 
of their physical function.
Sarcopenia
Table 2–Table 12 show that HCS has collected a wealth of markers 
of the mass, strength, function and morphology of muscle. Together, 
these have enabled a rich body of research on the predictors and 
consequences of sarcopenia.
Descriptive epidemiology. Sarcopenia may be defined by one or 
more of the markers collected in HCS, inter-relationships between 
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which have been explored in detail42,43. The prevalence of sarco-
penia across HCS, estimated according to European Working 
Group for Sarcopenia in Older People (EWGSOP) guidelines, but 
with lean mass estimated by skinfold measurements, was 4.6% 
in men and 7.9% in women44. For subgroups of HCS in which 
imaging and anthropometric data coexist, estimates of preva-
lence have been calculated according to more than one opera-
tional definition of sarcopenia (EWGSOP; International Working 
Group on Sarcopenia; Foundation for the National Institutes 
of Health sarcopenia project; dysmobility syndrome), enabling 
the methods to be compared directly44,45. Late-life declines in 
muscle mass as well as strength have been observed using data 
from two of the time points shown on Figure 2 (MSFU and 
EPOSA); these data suggest that muscle mass declines less 
rapidly than strength or function46.
Predictors of sarcopenia. The early-life origins of sarcope-
nia have been investigated using data from the Health Visitors’ 
records. Weights at birth and one year of age have been related 
to adult anthropometry, showing that whilst BMI and lean mass 
rise with birthweight and with weight at one, fat mass has asso-
ciations only with the latter47. This suggests that whilst the 
prenatal environment affects lean mass, the postnatal environ-
ment is more influential in the development of adult adiposity. 
Direct measures of muscle size from pQCT scanning have con-
firmed that birthweight is associated with muscle area in the calf 
and forearm48, whilst biopsies showed that smaller babies have 
lower total myofibre scores (kg/mm2) than those who were 
bigger at birth49. Grip strength was more strongly associated 
with birth weight than with growth during the first year of life 
in HCS participants50. This again suggests that sarcopenia has 
primarily pre- rather than post-natal origins, though there is 
some evidence to link breast feeding during infancy with 
increased grip strength51. A systematic review and meta-analysis 
of work in HCS and other cohorts showed that the positive 
relationship between birth weight and muscle strength exists 
across the lifecourse52.
The effects of adult lifestyle on risk of sarcopenia have also 
been investigated. First, to examine the role of diet, associations 
of grip strength with specific nutrients, individual foods and 
dietary patterns were studied. Healthier diets were associated 
with higher grip strength, although the strongest association was 
with more frequent consumption of oily fish53. Physical activity in 
old age, objectively measured by accelerometry, was found to be 
associated with decreased risk of EWGSOP sarcopenia and 
improved physical function, though not with grip strength54. 
Grip strength was not associated with lifetime occupational 
exposure to physically demanding activities55, a somewhat 
surprising finding in the light of evidence of social patterning in 
sarcopenia56. The role of adult heath in causal paths to sarco-
penia has also been investigated, identifying multimorbidity57, 
inflammaging58, and some59, but not all60, cardiovascular drugs 
as important influences.
Outcomes of sarcopenia. Sarcopenia has profound conse-
quences for health and wellbeing in later life and is associated 
in HCS with increased risk of hospital admission61. Changes in 
ageing muscle have been shown to contribute to the metabolic 
syndrome and all its components62; to self-rated health and 
health-related quality of life63; and to bone mineral content64. 
Together with strong independent relationships between muscle 
and bone size/strength65, this latter finding supports the existence 
of a muscle/bone unit and provides some insight into the 
mechanisms that underlie it.
Diet
Determinants of diet quality. The HCS has described marked 
differences in dietary choices in later life. For example, healthier 
diets have been found to be associated with being female, 
reporting a non-manual social class, and with being a 
non-smoker66. Psychological and social factors have important 
influences67, greater involvement in social activities being 
associated with slower declines in diet quality68. In addition, 
a relationship has been described between infant feeding and 
health behaviours in later life, such that people who were 
breastfed as infants were more likely to have healthier diets69.
Outcomes of diet quality. Our studies have described links 
between differences in nutrient intake and physical functioning 
in older women70, and shown that there is a graded increase in 
the prevalence of poor physical functioning in older adults as the 
number of risk factors (from obesity, smoking and poor diet) 
increases71. Less healthy diets also contribute to risk of hospital 
admission72. Additionally, higher processed meat consump-
tion and antioxidant intake have been related to poorer lung 
function in HCS73, while low dietary antioxidants were also 
associated with poorer glucose tolerance74.
Methodology. Assessment of diet in older populations can be 
burdensome. In HCS, a short food frequency questionnaire was 
therefore developed and validated to assess compliance with a 
healthy dietary pattern in older community-dwelling adults75.
Routinely collected data
The Medical Research Council76 and the Wellcome Trust77 
have advocated for the scientific and interdisciplinary poten-
tial of cohorts to be enhanced through linkage to routine health 
records and administrative datasets. Such linkage is particu-
larly valuable in an ageing cohort like HCS, where attrition 
may lead to bias if data collection requires participant contact. 
Successful linkage has been achieved in HCS with mortality 
and Hospital Episode Statistics (HES) data (Table 12), though 
difficulties persist over data access due to constantly changing 
regulations.
Mortality
In total, the 1911 to 1939 Hertfordshire birth cohort comprises 
37 000 men and women, 7916 of whom had died by the end of 
1999. Risk of death from circulatory disease was lower among 
men and women who were heavier at birth. Women who were 
heavier at birth also had lower risk of death from pneumonia, 
injury, diabetes, and musculoskeletal disease78.
Hospital care
HCS was one of the first English cohorts to link with HES data 
and produced early evidence on the descriptive epidemiology of 
hospital admissions among older individuals10. Such individual 
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level data contrast with published statistics, which are at the popu-
lation level. A novel methodology was developed to explore risk 
factors for admission in these multiple-failure survival data79, 
demonstrating links between admission and grip strength61, and 
showing that poor lifestyle risk factors have a cumulative effect 
on likelihood of admission72.
Genetics and epigenetics
Since its inception, HCS has studied the genetics of muscu-
loskeletal ageing. The scientific approach has evolved across the 
years, alongside dramatic changes in the technologies available 
to characterise the genome. Early studies of genetic influences 
on adult disease in HCS considered the role of single nucleotide 
polymorphisms (SNPs) and their specific interaction with early 
life phenotypes as predictors of muscle and bone health in later 
life80,81. Haplotype studies followed81–83, and more recently HCS 
has been an important contributor to many genome wide asso-
ciation studies conducted by worldwide consortia84,85. Finally, in 
the Hertfordshire Sarcopenia Study (HSS), participation in the 
industry funded MEMOSA (Multi-Ethnic MOlecular determi-
nants of human SArcopenia) collaboration has permitted cut-
ting edge scientific techniques such as deep sequencing of RNA 
as well as high coverage methylation arrays to be completed in a 
subset of participants. Furthermore, muscle cells obtained from 
biopsies of older men and women have been cultured in vitro 
providing a biobank that together with RNA and methylation 
data, will permit the investigation of genetic and epigenetic 
pathways in musculoskeletal ageing. This is an exciting area for 
future research in HCS
National and international collaborations
The HCS research group has a long and successful history of 
conducting collaborative research; principal local, national and 
international collaborators are detailed in Table 13. The nature 
of HCS collaborations varies widely, all are welcomed by the 
HCS research team. For example, bespoke results from statisti-
cal analyses and/or datasets have been provided to collaborators 
(ranging from PhD students to established research groups and 
international consortia) for inclusion in systematic reviews and 
meta-analyses. In other instances, students have visited the 
MRC LEU and worked alongside the HCS research team to 
conduct a specific sub-study or to run statistical analyses and 
draft a paper for publication. Another mode of collaboration 
is the provision of biological samples (e.g. plasma or DNA) to 
research groups and their laboratories; the information that they 
generate is returned to the HCS research team for inclusion in the 
master HCS databases. The resulting enhanced database is either 
analysed by HCS statisticians or released to the collaborators 
for them to analyse; either approach results in a jointly authored 
peer reviewed publication. Finally, the HCS research team may 
collaborate by submitting an ethics application jointly with a 
research group and conducting the study together; for example, 
the HPAT physical activity trial, the wellbeing follow-up study, 
and the VIBE study were conducted in collaboration with the 
MRC Epidemiology Unit (University of Cambridge), the MRC 
Unit for Lifelong Health and Ageing (at UCL) and the Univer-
sity of Bristol, respectively (see Figure 2 for timeline of HCS 
sub-studies).
The future
HCS is a flagship cohort that has demonstrated lifecourse 
influences on musculoskeletal health in later life. All of the 
information collected to date is extensively documented and 
carefully curated and, as evidenced by a broad body of col-
laborators and over 250 peer-reviewed publications to date, the 
cohort will continue to be an invaluable resource for national and 
international research on the lifecourse determinants of mus-
culoskeletal health in later life. Cohort members remain flagged 
with NHS Digital for ongoing notification of death, and further 
extracts of HES data would enable long-term follow-up of 
morbidity for the whole cohort (subject to funding and permission 
to access data). 
Two examples of future research areas in HCS are: first, 
development of lifecourse interventions to promote maintenance 
of health, and slow loss of function, of the musculoskeletal 
system in later life; and second, investigation of the mechanisms 
that explain how early life environment influences health in later 
life.
The ambition to develop lifecourse interventions to maintain 
the health of the musculoskeletal system in later life is a natural 
progression from the epidemiological studies that have been 
conducted in HCS and other cohorts to date. Diet and physical 
activity are now well established as key influences on muscu-
loskeletal health in later life, but research in HCS and elsewhere 
has shown that lifestyle risk factors cluster together to impact 
on physical function in later life71. Therefore, any lifestyle 
based intervention strategy would be well advised to adopt a 
holistic whole-person approach. Accordingly, the HCS research 
team’s objective is to develop and test the feasibility of a com-
bined healthy conversation and physical activity intervention 
to promote muscle mass, strength and function in later life 
with the ultimate aim of preventing falls and fractures. If this is 
successful, the intervention will be implemented more widely and 
its efficacy evaluated.
Epigenetics is an important area for research that seeks to 
move from epidemiological associations to identification of the 
mechanisms that underpin early life influences on health in later 
life. Epigenetics is the study of changes in organisms caused by 
modification of gene expression rather than alteration of the 
genetic code itself. For example, in HSS and HSSe participants, 
we are in the early phase of investigating whether the expres-
sion of genes associated with cellular pathways is altered during 
muscle ageing and how this contributes to sarcopenia. We are 
also studying genes associated with inflammation, mitochondrial 
function and the regulation of muscle growth, and taking the 
novel approach of investigating epigenetic pathways by studying 
DNA methylation markers in muscle tissue and also in cultured 
primary skeletal muscle cells. The results from this work will 
give us clues about how sarcopenia begins, progresses, and what 
can be done to prevent or treat it.
Epigenetics underpins the ambition to expand HCS to an 
intergenerational study. The theory of transgenerational epigenet-
ics implies that maternal environment during pregnancy transmits 
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to offspring and affects their subsequent gene expression86. An 
intergenerational study in HCS is a very special opportunity to 
investigate how epigenetic expression transmits across gen-
erations, and indeed to explore commonalities and differences 
in musculoskeletal health across generations. To date, more than 
1,000 members of the HCS cohort (the ‘F0 generation’) have 
provided us with the names and contact details of their children 
(the ‘F1 generation’) and grandchildren (the ‘F2 generation’). 
We are now in the process of recruiting these children and 
grandchildren to an HCS three generation cohort (HCS 3G); in 
the first instance we are seeking their consent to contact them 
in the future with invitations to participate in specific studies 
as they are planned. To date, more than 700 children and 
grandchildren have agreed to be members of the HCS 3G study. 
Following on in the tradition of their parents or grandparents who 
have participated so generously in HCS, these people will make 
an important contribution to our understanding of lifecourse and 
intergenerational influences on musculoskeletal health. 
Data availability
Hospital Episode Statistics and mortality data were obtained 
from NHS Digital under Data Sharing Agreements numbered 
148284 and 343023; but cannot be made openly available 
for ethical reasons. HCS data collected directly by the MRC 
LEU are accessible via collaboration with the HCS research 
group as described above. Initial enquires should be made to 
Professor Cyrus Cooper (Principal Investigator, e-mail: cc@mrc.
soton.ac.uk). Potential collaborators will be sent a collaborators’ 
pack and asked to submit a detailed study proposal to the HCS 
Steering Group; applications will be reviewed at the first available 
steering group meeting (held three times annually).
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